| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-9 | Gemcitabine | pancreatic cancer | Sensitive | High | 21347785 | |
| miR-99b | Gemcitabine | Bladder Carcinoma | Resistant | High | 23946872 | |
| miR-99b | Gemcitabine | cholangiocarcinoma | Resistant | High | 24147037 | |
| miR-920 | Gemcitabine | pancreatic cancer | Sensitive | High | 25117811 | |
| miR-921 | Gemcitabine | pancreatic cancer | Sensitive | High | 25117811 | |
| miR-92b | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| miR-939 | Gemcitabine | pancreatic cancer | Sensitive | High | 25117811 | |
| miR-940 | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| miR-96 | Gemcitabine | pancreatic cancer | Sensitive | High | 25117811 | |
| miR-98 | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| miR-99a | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| miR-935 | Gemcitabine | pancreatic cancer | Sensitive | High | 25149530 | |
| miR-99b* | Gemcitabine | pancreatic cancer | Resistant | High | 25149530 | |
| miR-99b | Gemcitabine | pancreatic ductal adenocarcinoma | Resistant | High | 25184537 | |
| miR-92b | Gemcitabine | pancreatic cancer | Resistant | High | 25722110 |